top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO

gdelacruz57
Jan 18, 2023
1 min read

Ramsey, Isle of Man, January 16, 2023 (Business Wire) -- Juvenescence has named Dr Richard Marshall CBE as its new CEO, effective 16 January 2023. Dr Marshall succeeds co-founder Dr Gregory Bailey, who will remain on the company’s board as Executive Chairman.

Read full article here.

Recent Posts

NewLimit Raises $130M to Advance Gene Reprogramming for Human Longevity, Reaches $810M Valuation

San Francisco, CA, May 6, 2025 (NewLimit) -- NewLimit, a biotech startup co-founded by Coinbase CEO Brian Armstrong, has raised $130...

Biohaven Lands Strategic $600M Deal with Oberland Capital to Fuel Troriluzole Launch and Pipeline Growth

New Haven, CT, April 28, 2025 (PRNewswire) -- Biohaven Ltd. has secured up to $600 million in non-dilutive financing from Oberland...

AEON Biopharma Appoints Industry Veteran Rob Bancroft as CEO

Irvine, CA, April 23, 2025 (Globe Newswire) -- AEON Biopharma has named Rob Bancroft as its new CEO as it accelerates development of...

Comments

Life Science Headlines

NewLimit Raises $130M to Advance Gene Reprogramming for Human Longevity, Reaches $810M Valuation

Biohaven Lands Strategic $600M Deal with Oberland Capital to Fuel Troriluzole Launch and Pipeline Growth

AEON Biopharma Appoints Industry Veteran Rob Bancroft as CEO

Merck Accelerates U.S. Expansion and Rare Tumor Strategy with $3.9B Acquisition of SpringWorks Therapeutics

RadNet to acquire iCAD for $103M to advance AI-powered breast cancer detection worldwide

Galapagos appoints Henry Gosebruch as Founding CEO of SpinCo amid strategic corporate separation

Glycomine raises $115M to advance first-in-class PMM2-CDG therapy GLM101 into Phase 2b trial

Calidi Biotherapeutics appoints Eric Poma as CEO to lead next phase of cancer virotherapy development

Repertoire partners with Genentech in $765M deal to develop T cell-targeted autoimmune therapies

AIRNA Raises $155M to Advance RNA Editing Therapy for Genetic Lung and Liver Disease

bottom of page